For full clinical trial data and what to expect at each dose level, see our guide: Retatrutide Results: Clinical Trial Weight Loss Data & Timelines
One study found that a weekly 2.4 mg dose led to a 20% reduction in major adverse cardiovascular events such as heart attack, stroke, or death among overweight or obese patients with existing cardiovascular disease, compared with a control group
Serious and less dangerous side effects occur most often after exceeding the dose, use despite contraindications, or independent use
In addition, semaglutide should not be prescribed along with several other medicines, including chloroquine, atogepant, and hydroxychloroquine, among several others, as it can lead to severe reactions
If you are the type of person who wants to try a product for 30 days before committing further, Brello is not structured to accommodate that preference
( B ) Plasma DPP4 activity